Filter
360
Filtered Results: 360
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
174
Guidelines
92
Studies & Reports
39
Manuals
20
Fact sheets
19
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
11
Germany
11
India
11
South Africa
10
Nigeria
8
Pakistan
8
Latin America and the Carribbean
7
Sierra Leone
6
Syria
6
Philippines
6
Ethiopia
6
Nepal
5
Afghanistan
5
Tanzania
5
Kenya
4
Ukraine
4
Chile
4
Uganda
4
Namibia
4
Rwanda
3
Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Russia
3
Yemen
3
Ecuador
3
Myanmar / Burma
3
Malawi
2
Venezuela
2
Congo, Democratic Republic of
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bangladesh
2
Papua New Guinea
2
Zambia
2
Liberia
2
North Macedonia
1
Colombia
1
Lesotho
1
Turkey
1
Gambia
1
China
1
Niger
1
Peru
1
Zimbabwe
1
Jordan
1
Paraguay
1
Bolivia
1
Argentina
1
Lebanon
1
Brazil
1
Egypt
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
110
Clinical Guidelines
49
Women & Child Health
17
Key Resources
9
Public Health
8
Pharmacy & Technologies
7
Capacity Building
1
Toolboxes
COVID-19
82
Polio
38
Rapid Response
25
TB
16
Ebola
16
Pharmacy
15
Refugee
14
HIV
11
NTDs
11
AMR
11
Conflict
8
Cholera
7
Zika
5
Natural Hazards
4
Planetary Health
3
Mental Health
2
Specific Hazards
1
Health Financing Toolbox
1
NCDs
1
Global Health Education
1
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
Updated 28 December 2020
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
News Release 11 april 2022
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
WHO Secretariat Information paper July 2016
